Stay updated on RadioSurgery and Nivolumab for Brain Metastases Clinical Trial
Sign up to get notified when there's something new on the RadioSurgery and Nivolumab for Brain Metastases Clinical Trial page.

Latest updates to the RadioSurgery and Nivolumab for Brain Metastases Clinical Trial page
- CheckyesterdayChange DetectedA site-wide notice announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to updates and FAQs.SummaryDifference1%

- Check8 days agoChange DetectedThe footer’s site revision changed from v3.7.1 to v3.7.2. The page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check15 days agoChange DetectedThe footer’s displayed ClinicalTrials.gov revision changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check36 days agoChange DetectedThe page now renders a 403 Forbidden error page (with a DOCTYPE header and minimal navigation) instead of the study record content. This indicates an access issue to the page rather than an update to the study data.SummaryDifference20%

- Check57 days agoChange DetectedThe page's revision tag was updated from v3.6.5 to v3.6.6. This indicates a new published version of the study details page.SummaryDifference0.1%

- Check78 days agoChange DetectedRevision: v3.6.5 was added and Revision: v3.6.4 was removed, indicating a new page build. This update concerns versioning and does not modify the study details shown on the page.SummaryDifference0.1%

Stay in the know with updates to RadioSurgery and Nivolumab for Brain Metastases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RadioSurgery and Nivolumab for Brain Metastases Clinical Trial page.